Replies to post #52237 on Biotech Values

[croumagnon]

RPRX "They were just trying to rationalize why the stock is being dumped today on reasonably good news."

That was certainly reasonably good news particularly that the phase II for Proellex is being conducted in 20 centers. There really is no rationalizing for the pull back lately and I am affraid it is more of the same manipulation that we are witnessing (I am ready for the attacks regarding conspiracy theories, but this conspiracy is at a very small scale as the volume would indicate and is being done by some would be micro hedgies in some shady basement I believe...).

The only viable explanation, besides the fact that the stock is an unknown to wall-street, is that people are putting more weight on Androxal than Proellex and some fear that a QOL requirement by the FDA would push the timeline out quite a bit. My own thinking is that RPRX is a gem and I am using this opportunity to carefully add to my position...

[AlpineBV_Miller]

Um, I don't think anyone on the RPRX board expected a phase III trial for Proellex in endometriosis. They were just trying to rationalize why the stock is being dumped today on reasonably good news.

Half the OPM runners I was contacted by today didn't discern between endo and fibroids. They sold first and asked questions later. I did a lot of head shaking after hanging up the phone today.